BioPharma Dive May 23, 2024
Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merck & Co., J&J and Arcus.
Today, we’re interrupting our usual rundown of industry news to highlight notable clinical trial updates ahead of next week’s American Society of Clinical Oncology’s annual meeting. On Thursday, conference organizers released abstracts, or snapshots, of most of the studies set to be presented at the meeting, which will be held in Chicago from May 31 to June 4.
Note: So-called late-breaking abstracts, which often feature particularly consequential trial findings, aren’t available until the day the relevant studies are presented. This year, that group includes anticipated data on Novartis’ therapy Scemblix in leukemia, GSK’s Blenrep in...
Today's Sponsors
Today's Sponsor